1-4 of 4
S Bauer
Close
Sort by
Journal Articles

Phase 1 Study of UCN-01 in Combination with Perifosine in Patients with Relapsed and Refractory Acute Leukemias and High Risk Myelodysplastic Syndromes (MDS)

Kelly J. Norsworthy, MD, Alexander E Perl, MD, Martin Carroll, MD, Selina M. Luger, MD, Kenneth S. Bauer, PharmD, PhD, Michael L. Tidwell, CRNP, Dina Ioffe, BA, Maria R. Baer, MD, Edward A. Sausville, MD, PhD, Ivana Gojo, MD
Journal: Blood
Blood (2011) 118 (21): 1557.
https://doi.org/10.1182/blood.V118.21.1557.1557
Published: 2011
Journal Articles

Prolonged Engraftment and/or Primary Graft Failure Following Allogenic Stem Cell Transplant in Patients Treated with Dasatinib.

Stephanie S. Bauer, APRN-BC, Jennifer C. Dykeman, BA, Kristan M. Augustin, PharmD, John F. DiPersio, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 5259.
https://doi.org/10.1182/blood.V108.11.5259.5259
Published: 2006
Journal Articles

T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28

C Renner, S Ohnesorge, G Held, S Bauer, W Jung, JP Pfitzenmeier, M Pfreundschuh
Journal: Blood
Blood (1996) 88 (1): 236–241.
https://doi.org/10.1182/blood.V88.1.236.236
Published: 1996
Journal Articles

Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model

C Renner, S Bauer, U Sahin, W Jung, R van Lier, G Jacobs, G Held, M Pfreundschuh
Journal: Blood
Blood (1996) 87 (7): 2930–2937.
https://doi.org/10.1182/blood.V87.7.2930.bloodjournal8772930
Published: 1996